Researchers at the University of Arkansas for Medical Sciences (UAMS) have been awarded $1.3 million to study disparities in immune response to SARS-CoV-2, known as COVID-19, through serological testing in Arkansas.
Serological testing measures a person’s immune response to an infection in the form of antibodies in the blood.
The project will contribute to short- and long-term impact of COVID-19 and the pandemic on the physical, psychological, and social health of underrepresented minority men and women in Arkansas.